HomeCompareDMGGF vs MRK

DMGGF vs MRK: Dividend Comparison 2026

DMGGF yields 1185.54% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DMGGF wins by $84381555.19M in total portfolio value
10 years
DMGGF
DMGGF
● Live price
1185.54%
Share price
$0.17
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$84381555.25M
Annual income
$72,372,794,181,752.62
Full DMGGF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — DMGGF vs MRK

📍 DMGGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDMGGFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DMGGF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DMGGF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DMGGF
Annual income on $10K today (after 15% tax)
$100,770.60/yr
After 10yr DRIP, annual income (after tax)
$61,516,875,054,489.73/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, DMGGF beats the other by $61,516,875,046,161.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DMGGF + MRK for your $10,000?

DMGGF: 50%MRK: 50%
100% MRK50/50100% DMGGF
Portfolio after 10yr
$42190777.65M
Annual income
$36,186,397,095,775.38/yr
Blended yield
85.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

DMGGF
No analyst data
Altman Z
0.6
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DMGGF buys
0
MRK buys
0
No recent congressional trades found for DMGGF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDMGGFMRK
Forward yield1185.54%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$84381555.25M$56.8K
Annual income after 10y$72,372,794,181,752.62$9,798.13
Total dividends collected$83484249.47M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DMGGF vs MRK ($10,000, DRIP)

YearDMGGF PortfolioDMGGF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$129,254$118,553.65$11,206$366.19+$118.0KDMGGF
2$1,570,403$1,432,101.95$12,650$502.35+$1.56MDMGGF
3$17,941,755$16,261,423.90$14,407$694.19+$17.93MDMGGF
4$192,829,177$173,631,498.69$16,585$967.82+$192.81MDMGGF
5$1,950,351,593$1,744,024,373.70$19,342$1,363.89+$1950.33MDMGGF
6$18,572,634,723$16,485,758,518.73$22,913$1,947.19+$18572.61MDMGGF
7$166,591,518,487$146,718,799,332.84$27,662$2,823.89+$166591.49MDMGGF
8$1,408,185,647,222$1,229,932,722,440.66$34,159$4,173.35+$1408185.61MDMGGF
9$11,223,141,186,698$9,716,382,544,170.67$43,337$6,308.80+$11223141.14MDMGGF
10$84,381,555,251,519$72,372,794,181,752.62$56,776$9,798.13+$84381555.19MDMGGF

DMGGF vs MRK: Complete Analysis 2026

DMGGFStock

DMG Blockchain Solutions Inc. operates as a blockchain and cryptocurrency company in Canada. The company manages, operates, and develops digital solutions to monetize the blockchain ecosystem. It also offers transaction verification; co-location hosting; data center optimization; and high-performance computing services. In addition, the company provides infrastructure consulting in various fields, including location and power infrastructure review, air flow and cooling contact, high and low voltage power design and engineering, and facility power distribution design and engineering. Further, the company develops and licenses proprietary blockchain and cryptocurrency software, comprising Mining Pool, an audited mining pool; WalletScore, a blockchain audit and analytics platform; Mine Manager, an optimization software for mining facilities; Blockseer Intelligence, an analytics tool that enables the tracking of cryptocurrency on Bitcoin and Ethereum blockchains; Blockseer Breeze, an enterprise-grade custody solution to securely manage digital assets; and BlockSeer Freeze, a software product that watches BTC wallets and provides early notification of transactions on the blockchain network. Additionally, it offers forensic services. The company was incorporated in 2011 and is headquartered in Grand Forks, Canada.

Full DMGGF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this DMGGF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DMGGF vs SCHDDMGGF vs JEPIDMGGF vs ODMGGF vs KODMGGF vs MAINDMGGF vs JNJDMGGF vs ABBVDMGGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.